Get our introductory offer at only
*$0.99/month for first 3 months
$29.90/month for the next 9 months
SHIRE plc, the drugmaker seeking to boost growth after its proposed sale to AbbVie Inc collapsed, agreed to buy NPS Pharmaceuticals Inc for about US$5.2 billion to add medicines used to treat rare diseases.
Shire will pay US$46 a share in cash, the Dublin-based company said...